Forget gold! I’d buy and hold these 2 FTSE 100 shares for 20 years

Gold seems attractive in uncertain times but it loses money over time! These 2 FTSE 100 shares could make you much richer, says Tom Rodgers.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Gold is often the first place new investors look when they are uncertain about the future of FTSE 100 shares.

The precious metal is a classic ‘hedge’ against falling share prices and rising inflation. The price of gold usually moves in the opposite direction to stock markets like the America’s S&P 500 or the FTSE 100.

And physical gold prices are now at all time highs at £1,400 per ounce.

But the numbers justifying holding gold long term don’t stack up. If you had bought gold in the 1970s, taking inflation into account, you would have actually made a loss on your investment for the past 40 years!

There are two elite FTSE 100 shares I believe will bring you much more long-term value.

Health revolution

GlaxoSmithKline (LSE:GSK) is not just leading the charge for a Covid-19 vaccine. It also has an unimpeachable economic moat, or competitive advantage.

GSK is so appealing to long-term investors because it can produce incredible repeat profits from its brands. And its intellectual property in the form of branded drug treatments makes it hard for other pharmaceutical companies to swoop in and steal market share.

Companies like GSK are rare favourites among FTSE 100 shares, firstly because they pay better-than-average dividends — a 4.8% yield at last count. And secondly, because they have strong earnings visibility, even in uncertain markets.

GSK’s share price has rebounded so quickly from the stock market crash of March, precisely because of its ability here. Its profits are rising even faster than revenue. 2018 was another bumper year, with £4.8bn profit, but 2019 was even better with £6.2bn.

One recent win demonstrates how it makes these long-term earnings. On 18 May, it hailed a breakthrough HIV treatment by one of its partner companies. Research bosses said they were “thrilled” with the results that the long-acting injectable treatment called cabotegravir can produce.

This is just one of GSK’s stable of healthcare treatments. It also has medications for common respiratory diseases like asthma. And not only are these helping to allieviate patient symptoms. They are also highly profitable for shareholders.

Renewable

When I think about the next 20 years I also believe that renewable energy will be a major driver for economies.

And in FTSE 100 shares, I’m looking at those profiting from the electric revolution in everything from cars to power plants.

My top choice here is SSE (LSE:SSE). The former Big Six energy supplier has seen which way the wind is blowing. Last year it offloaded its consumer division to Ovo Energy to focus solely on building renewable infrastructure.

This move is already having a major impact. Company profits leapt from £864m on revenue of £26bn in 2018, to £1.7bn on revenue of £7bn in 2019.

SSE says its investment case “rests on its clear dividend commitment” and I am minded to agree. At a time when 45% of FTSE companies have stopped or reduced dividends, it pays an 8.2% yield. Today’s share price is around the average of FTSE 100 shares at 17 times earnings.

The UK is already the world’s largest market for offshore wind. And SSE’s investment in core infrastructure is key for the UK government to meet its legally-binding target to produce net zero carbon by 2050.

Zoom out from the day-to-day to consider the future. I think these FTSE 100 shares will make a much better long-term investment than gold.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Tom Rodgers has no position in the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

After it crashed 25%, should I buy this former stock market darling in my Stocks and Shares ISA?

Harvey Jones has a big hole in his Stocks and Shares ISA that he is keen to fill. Should he…

Read more »

happy senior couple using a laptop in their living room to look at their financial budgets
Investing Articles

How’s the dividend forecast looking for Legal & General shares in 2025 and beyond?

As a shareholder, I like to keep track of the potential dividend returns I could make from my Legal &…

Read more »

artificial intelligence investing algorithms
Investing Articles

Could buying this stock with a $7bn market cap be like investing in Nvidia in 2010?

Where might the next Nvidia-type stock be lurking in today's market? Our writer takes a look at one candidate with…

Read more »

Investing Articles

Is GSK a bargain now the share price is near 1,333p?

Biopharma company GSK looks like a decent stock to consider for the long term, so is today's lower share price…

Read more »

Snowing on Jubilee Gardens in London at dusk
Investing Articles

Could December be a great month to buy UK shares?

Christopher Ruane sees some possible reasons to look for shares to buy in December -- but he'll be using the…

Read more »

Young mixed-race couple sat on the beach looking out over the sea
Investing Articles

Sticking to FTSE shares, I’d still aim for a £1,000 monthly passive income like this!

By investing in blue-chip FTSE shares with proven business models, our writer hopes he can build sizeable passive income streams…

Read more »

Growth Shares

BT shares? I think there are much better UK stocks for the long term

Over the long term, many UK stocks have performed much better than BT. Here’s a look at two companies that…

Read more »

British Pennies on a Pound Note
Investing Articles

After a 540% rise, could this penny share keep going?

This penny share has seen mixed fortunes in recent years. Our writer looks ahead to some potentially exciting developments in…

Read more »